eEF2K: an atypical kinase target for cancer

Nat Rev Drug Discov. 2021 Aug;20(8):577. doi: 10.1038/d41573-021-00124-5.
No abstract available

MeSH terms

  • Elongation Factor 2 Kinase / antagonists & inhibitors*
  • Humans
  • Molecular Targeted Therapy*
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology
  • Neoplasms / pathology
  • Protein Kinase Inhibitors / therapeutic use*
  • Signal Transduction

Substances

  • Protein Kinase Inhibitors
  • EEF2K protein, human
  • Elongation Factor 2 Kinase